Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences

被引:41
作者
Kaul, M
Yu, H
Ron, Y
Dougherty, JP
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Grad Program Microbiol & Mol Genet, New Brunswick, NJ 08903 USA
关键词
D O I
10.1006/viro.1998.9327
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Packaging cell lines derived from human immunodeficiency virus-1 (HIV-1) are promising tools for in vivo somatic cell gene therapy protocols due to the ability of lentiviruses to infect nondividing cells. We describe here the generation of a safe, stable HIV-1 packaging cell line capable of expressing all of the HIV-1 structural, enzymatic, and regulatory proteins but lacking majority of the cis-acting sequences. The use of an inducible expression system circumvented the cytotoxic and cytostatic effects associated with the expression of some of the HIV-1 viral proteins. Reverse transcriptase activity was detectable in the supernatant from the stable packaging line 1 day after induction, while vector titers peaked 5 days postinduction. Vector titers of up to 3.5 x 10(4) infectious units/ml (IU/ml) were maintained through 8 months following the establishment of the cell line. Lineage-specific gene delivery can be achieved from this established cell line as viral stocks obtained specifically infect CD4(+) target cells. Moreover, this cell line provides a safe and easy to use system for screening of drugs that inhibit HIV-1 replication. (C) 1998 Academic Press.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 40 条
[2]   Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein [J].
Bartz, SR ;
Vodicka, MA .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 12 (04) :337-342
[3]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[4]   CONSTRUCTION OF A FUSION GENE THAT CONFERS RESISTANCE AGAINST HYGROMYCIN-B TO MAMMALIAN-CELLS IN CULTURE [J].
BERNARD, HU ;
KRAMMER, G ;
ROWEKAMP, WG .
EXPERIMENTAL CELL RESEARCH, 1985, 158 (01) :237-243
[5]  
Blomer U, 1997, J VIROL, V71, P6641
[6]   GREEN FLUORESCENT PROTEIN AS A MARKER FOR GENE-EXPRESSION [J].
CHALFIE, M ;
TU, Y ;
EUSKIRCHEN, G ;
WARD, WW ;
PRASHER, DC .
SCIENCE, 1994, 263 (5148) :802-805
[7]   Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line [J].
Corbeau, P ;
Kraus, G ;
WongStaal, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14070-14075
[8]   ANALYSIS OF MUTATION IN HUMAN-CELLS BY USING AN EPSTEIN-BARR-VIRUS SHUTTLE SYSTEM [J].
DUBRIDGE, RB ;
TANG, P ;
HSIA, HC ;
LEONG, PM ;
MILLER, JH ;
CALOS, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (01) :379-387
[9]   GENES WITH PROMOTERS IN RETROVIRUS VECTORS CAN BE INDEPENDENTLY SUPPRESSED BY AN EPIGENETIC MECHANISM [J].
EMERMAN, M ;
TEMIN, HM .
CELL, 1984, 39 (03) :459-467
[10]   HIV-I INFECTION OF NONDIVIDING CELLS - C-TERMINAL TYROSINE PHOSPHORYLATION OF THE VIRAL MATRIX PROTEIN IS A KEY REGULATOR [J].
GALLAY, P ;
SWINGLER, S ;
AIKEN, C ;
TRONO, D .
CELL, 1995, 80 (03) :379-388